Acurx Pharmaceuticals, Inc. (ACXP) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings. Welcome to Acurx Pharmaceuticals to discuss Second Quarter twenty twenty six Financial Results on 08/14/2026 Conference Call and provide business update. At this time, all participants will be in listen only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. I'll now turn the conference over to Rob Shawa, Chief Financial Officer. Thank you. You may begin. Thank you, Rob. Good morning, and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the second quarter of twenty twenty six, which is available on our website at acurxpharma.com. Joining me today is Dave Lucey, President and CEO of Acurx, who will start by providing a corporate update and outlook. Following that, I'll provide some highlights of the financials from the second quarter ended June 30 and then turn the call back over to Dave for his closing remarks. As a reminder, during today's call, we'll be making certain forward looking statements, which are based on current information, assumptions, estimates and projections about future events that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward looking statements. Investors should consider these risks and other information described in our filings with the Securities and Exchange Commission, including our quarterly report on Form 10 Q, which we filed yesterday, Thursday, 08/13/2026. You are cautioned not to place undue reliance on these forward looking statements, and Acurx disclaims any obligation to update such statements at any time in the future. This conference call contains time sensitive information that's ...